Skip to content

Downloads

Date Title Documents

REVEAL FAQ

Amarin Q2 2017 Earnings Presentation

Amarin Q1 2017 Earnings Presentation

2017 Proxy Statement

2016 AMCO Statutory Accounts

View Presentation

ADR List for 2018

Amarin Q2 2016 Results

2016 Proxy Statement

AMRN.pdf

copyright
© 2018, Amarin Corporation
Privacy policy  |  Disclaimer
Dublin Office
2 Pembroke House, Upper Pembroke
Street 28-32
Dublin 2, Ireland
US Investor Relations
Amarin Pharma Inc.
1430 Route 206
Bedminster, NJ 07921 USA
Telephone:
+1 908 719 1315
Fax:
+1 908 719 3012

Amarin Corporation